These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3814500)

  • 1. Histochemical and ultrastructural study of renal cortical necrosis in rats treated with oestrone + vasopressin, and its prevention with a vasopressin antagonist.
    Kocsis J; Karácsony G; Karcsú S; László FA
    Br J Exp Pathol; 1987 Feb; 68(1):35-43. PubMed ID: 3814500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the anti-oestrogen tamoxifen on the development of renal cortical necrosis induced by oestrone + vasopressin administration in rats.
    Kocsis J; Karácsony G; Karcsú S; László FA
    Br J Exp Pathol; 1988 Apr; 69(2):157-67. PubMed ID: 3377960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vasopressin antagonist on vasopressin binding, adenylate cyclase activation, and water flux.
    Kim JK; Dillingham MA; Summer SN; Ishikawa S; Anderson RJ; Schrier RW
    J Clin Invest; 1985 Oct; 76(4):1530-5. PubMed ID: 2997281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and heart rate effect of a vasopressin antagonist in conscious normotensive rats pretreated with exogenous vasopressin.
    Waeber B; Nussberger J; Brunner HR
    Eur J Pharmacol; 1983 Jul; 91(1):135-7. PubMed ID: 6688586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a vasopressin antagonist d(CH2)5Tyr(Met)AVP on the development of renal vasospasm induced by estrin plus vasopressin administration in rats.
    Kocsis J; Szabó E; László FA
    Invest Radiol; 1987 Dec; 22(12):973-7. PubMed ID: 3440733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyproterone acetate-promoted prevention of renal cortical necrosis following testosterone and vasopressin administration.
    Mónus Z; László FA
    Br J Exp Pathol; 1979 Feb; 60(1):72-5. PubMed ID: 465307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery.
    Clineschmidt BV; Lis EV
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):72-84. PubMed ID: 2950833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
    László FA; Laczi F; Janáky T; Baláspiri L
    Endocr Regul; 1991 Sep; 25(3):181-3. PubMed ID: 1764609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of testosterone-vasopressin induced necrosis of the kidney cortex by cyproterone acetate].
    Mónus Z; László F
    Morphol Igazsagugyi Orv Sz; 1979 Jul; 19(3):226-9. PubMed ID: 503094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin.
    Yared A; Kon V; Ichikawa I
    J Clin Invest; 1985 May; 75(5):1477-87. PubMed ID: 3998146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference between male and female rats in vasopressor response to arginine vasopressin.
    László FA; Varga C; Papp A; Pávó I; Fahrenholz F
    Acta Physiol Hung; 1993; 81(2):137-45. PubMed ID: 8197870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressor and renal vasoconstrictor effects of NG-nitro-L-arginine as affected by blockade of pressor mechanisms mediated by the sympathetic nervous system, angiotensin, prostanoids and vasopressin.
    Pucci ML; Lin L; Nasjletti A
    J Pharmacol Exp Ther; 1992 Apr; 261(1):240-5. PubMed ID: 1560371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histochemical studies of hormone induced renal cortical necrosis].
    Horváth E; Kovács K
    Pathol Eur; 1968; 3(1):27-48. PubMed ID: 5670418
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors.
    Cooper CL; Malik KU
    J Pharmacol Exp Ther; 1984 Apr; 229(1):139-47. PubMed ID: 6423810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical and neuro-humoral factors in acute aortic coarctation hypertension.
    Salgado HC; Fazan R; Machado BH; Salgado MC
    Agents Actions Suppl; 1992; 36():152-63. PubMed ID: 1609637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate.
    László FA; Csáti S; Baláspiri L
    Acta Endocrinol (Copenh); 1984 May; 106(1):56-60. PubMed ID: 6730855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct inhibition by non-peptide and peptide arginine vasopressin antagonists of vasopressin-induced activation of mitogen-activated protein kinase in cultured rat vascular smooth muscle cells.
    Okada K; Sasaki R; Ishikawa S; Saito T
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1155-60. PubMed ID: 8179597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressor-type vasopressin receptors in the adrenal cortex: properties of binding, effects on phosphoinositide metabolism and aldosterone secretion.
    Balla T; Enyedi P; Spät A; Antoni FA
    Endocrinology; 1985 Jul; 117(1):421-3. PubMed ID: 2988926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amygdalar injections of vasopressin and its antagonist do not disrupt the circadian rhythm of food and water intake in the rat.
    Reghunandanan V; Marya RK; Maini BK; Reghunandanan R
    Indian J Physiol Pharmacol; 1988; 32(2):114-9. PubMed ID: 3182058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.